Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Greenwich Lifesciences Inc
(NQ:
GLSI
)
13.59
+0.24 (+1.80%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Greenwich Lifesciences Inc
< Previous
1
2
3
Next >
5 Short Squeeze Stocks That May Soar Plus 5 To Watch: ToughBuilt, Redbox, Revlon And More
August 08, 2022
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move.
Via
Benzinga
Greenwich LifeSciences Provides Updates on Flamingo-01 Phase III Clinical Trial
August 03, 2022
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Greenwich LifeSciences Provides Financing Strategy & Corporate Update
July 28, 2022
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Twitter, Delta Air Lines And 45 Stocks Moving In Wednesday's Mid-Day Session
July 13, 2022
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 122.4% to $6.76. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.
Via
Benzinga
This Healthcare Stock is Down By More Than 50%: Here's 25 Stocks Moving Premarket
July 13, 2022
Gainers
Via
Benzinga
Boeing, PriceSmart And 80 Biggest Movers From Yesterday
July 13, 2022
Gainers Sharps Compliance Corp. (NASDAQ: SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be acquired by an affiliate of Aurora Capital Partners for $8.75 per share.
Via
Benzinga
Crude Oil Prices Fall Sharply; Greenwich LifeSciences Shares Spike Higher
July 12, 2022
U.S. stocks traded mixed toward the end of trading after recording losses in the previous session.
Via
Benzinga
Here's Why Greenwich Lifesciences Shares Are Popping Off Today
July 12, 2022
Greenwich Lifesciences Inc (NASDAQ: GLSI) shares are trading higher by 32.95% to $11.46 Tuesday afternoon after the FDA removed the clinical hold on the company's Flamingo-01 Phase 3 trial of GP2.
Via
Benzinga
U.S. Stocks Turn Higher; PepsiCo Posts Upbeat Q2 Results
July 12, 2022
U.S. stocks turned higher midway through trading after recording losses in the previous session.
Via
Benzinga
Why Is Canoo Surging By 80%? 52 Stocks Moving In Tuesday's Mid-Day Session
July 12, 2022
Gainers
Via
Benzinga
Versus Systems (VS) Stock Roars After Nasdaq Warning
July 12, 2022
Versus Systems (VS) stock is rising higher on Tuesday after getting a delisting warning from the Nasdaq Exchange about a month ago.
Via
InvestorPlace
Why Is Greenwich Lifesciences (GLSI) Stock Up Today?
July 12, 2022
Greenwich Lifesciences (GLSI) stock is heading higher on Tuesday after the FDA lifted a hold on a Phase III clinical trial.
Via
InvestorPlace
Why Markets Are Trading Mixed; US Small Business Optimism Tumbles To This Level
July 12, 2022
U.S. stocks traded mixed this morning after recording losses in the previous session.
Via
Benzinga
The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner
July 12, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Greenwich LifeSciences Announces Removal of Clinical Hold Permitting Phase III Clinical Trial to Proceed
July 12, 2022
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Greenwich LifeSciences Announces Suspension of Share Repurchase Program
July 11, 2022
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session
June 28, 2022
Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.
Via
Benzinga
Greenwich LifeSciences to Resume Stock Repurchase Program
May 23, 2022
From
Greenwich LifeSciences, Inc.
Via
Business Wire
91 Biggest Movers From Friday
June 13, 2022
Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.
Via
Benzinga
69 Biggest Movers From Yesterday
June 10, 2022
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares climbed 189.9% to close at $1.12 on Thursday.
Via
Benzinga
Greenwich LifeSciences Provides Updates on Upcoming Phase III Clinical Trial & ASCO Meeting
May 23, 2022
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Wednesday
June 01, 2022
On Wednesday, 73 stocks hit new 52-week lows.
Via
Benzinga
Greenwich LifeSciences to Participate in Upcoming Jefferies, Wainwright, ASCO and BIO International Conferences
April 20, 2022
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Greenwich LifeSciences Presents Phase IIb Data, Published at AACR 2022, Further Supporting the Role of GP2 in Preventing Metastatic Breast Cancer
April 19, 2022
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Recession Fears are Creating a Golden Opportunity for Biotech Stocks
April 08, 2022
Biotech stocks are hard for novice investors to successfully profit from, but it's worth your time to learn the techniques now.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 23, 2022
Gainers Greenwich LifeSciences (NASDAQ:GLSI) stock moved upwards by 9.6% to $23.84 during Wednesday's after-market session. The market value of their outstanding shares is at $312.8 million. As per the...
Via
Benzinga
Greenwich LifeSciences to Present at 2022 BIO CEO & Investor Conference
February 03, 2022
From
Greenwich LifeSciences, Inc.
Via
Business Wire
78 Biggest Movers From Friday
February 14, 2022
Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab. China Online Education...
Via
Benzinga
Greenwich LifeSciences Provides Update on Upcoming Phase III Clinical Trial, FLAMINGO-01
February 01, 2022
From
Greenwich LifeSciences, Inc.
Via
Business Wire
62 Biggest Movers From Yesterday
February 11, 2022
Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares jumped 42.8% to close at $3.07 on Thursday following the company's recent uplisting to the Nasdaq....
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.